Actively Recruiting

Phase 2
Age: 18Years - 70Years
All Genders
NCT06912165

A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis

Led by Zhejiang Wenda Pharma Technology LTD. · Updated on 2025-04-11

140

Participants Needed

1

Research Sites

47 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Th purpose of the study is to evaluate the dose response of WD-890 in efficacy at Week 16 in participants with moderate-to-severe plaque psoriasis.

CONDITIONS

Official Title

A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female aged 18 to 70 years (inclusive) at time of consent
  • Diagnosed with plaque psoriasis for at least 6 months before screening
  • Psoriasis covers at least 10% of body surface area at screening and randomization
  • Psoriasis Area and Severity Index (PASI) score of 12 or higher at screening and randomization
  • Static Physician's Global Assessment (sPGA) score of 3 or higher at screening and randomization
Not Eligible

You will not qualify if you...

  • Having a nonplaque form of psoriasis (such as erythrodermic, guttate, inverse, pustular, or drug-induced psoriasis)
  • Uncontrolled arterial hypertension with systolic blood pressure of 160 mm Hg or higher or diastolic blood pressure of 100 mm Hg or higher, confirmed by two consecutive readings
  • Class III or IV congestive heart failure according to New York Heart Association criteria
  • History of chronic bacterial infections such as chronic pyelonephritis, chronic bronchiectasis, or chronic osteomyelitis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences, Peking Union Medical College

Nanjing, Jiangsu, China, 210000

Actively Recruiting

Loading map...

Research Team

Q

Qianjin Lu, doctor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis | DecenTrialz